Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.
Arnsten AF, Girgis RR, Gray DL, Mailman RB. Arnsten AF, et al. Among authors: gray dl. Biol Psychiatry. 2017 Jan 1;81(1):67-77. doi: 10.1016/j.biopsych.2015.12.028. Epub 2016 Jan 18. Biol Psychiatry. 2017. PMID: 26946382 Free PMC article. Review.
Dopaminergic D1 Receptor Stimulation Affects Effort and Risk Preferences.
Soutschek A, Gvozdanovic G, Kozak R, Duvvuri S, de Martinis N, Harel B, Gray DL, Fehr E, Jetter A, Tobler PN. Soutschek A, et al. Among authors: gray dl. Biol Psychiatry. 2020 Apr 1;87(7):678-685. doi: 10.1016/j.biopsych.2019.09.002. Epub 2019 Sep 12. Biol Psychiatry. 2020. PMID: 31668477 Free article. Clinical Trial.
The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study.
Huang X, Lewis MM, Van Scoy LJ, De Jesus S, Eslinger PJ, Arnold AC, Miller AJ, Fernandez-Mendoza J, Snyder B, Harrington W, Kong L, Wang X, Sun D, Delnomdedieu M, Duvvuri S, Mahoney SE, Gray DL, Mailman RB. Huang X, et al. Among authors: gray dl. J Parkinsons Dis. 2020;10(4):1515-1527. doi: 10.3233/JPD-202188. J Parkinsons Dis. 2020. PMID: 32986682 Free PMC article. Clinical Trial.
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.
Abi-Dargham A, Javitch JA, Slifstein M, Anticevic A, Calkins ME, Cho YT, Fonteneau C, Gil R, Girgis R, Gur RE, Gur RC, Grinband J, Kantrowitz J, Kohler C, Krystal J, Murray J, Ranganathan M, Santamauro N, Van Snellenberg J, Tamayo Z, Wolf D; TRANSCENDS Group; Gray D, Lieberman J. Abi-Dargham A, et al. Schizophr Bull. 2022 Jan 21;48(1):199-210. doi: 10.1093/schbul/sbab095. Schizophr Bull. 2022. PMID: 34423843 Free PMC article.
A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity.
Balice-Gordon R, Honey GD, Chatham C, Arce E, Duvvuri S, Naylor MG, Liu W, Xie Z, DeMartinis N, Harel BT, Braley GH, Kozak R, Park L, Gray DL. Balice-Gordon R, et al. Among authors: gray dl. Int J Neuropsychopharmacol. 2020 May 27;23(5):287-299. doi: 10.1093/ijnp/pyaa007. Int J Neuropsychopharmacol. 2020. PMID: 32055822 Free PMC article. Clinical Trial.
153 results